John A. Lewicki, EVP, Research & Development at OncoMed Pharmaceuticals Inc (OMED), sold 11,465 shares at $9.06 ($104K) on 2017-04-04, disclosed to the SEC on 2017-04-05.
Open-market sale of $104k OMED by EVP, Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.87 | 43 | $381 | 0.4% |
| 2 | $9.06 | 5,711 | $52K | 49.8% |
| 3 | $9.06 | 5,711 | $52K | 49.8% |
| Total | $9.06 avg | 11,465 | $104K | 100% |
| Filing → |
| OMED | SELL | 2018-10-11 | $2K | — | Filing → |
| OMED | SELL | 2018-10-10 | $5K | — | Filing → |
| OMED | SELL | 2018-04-26 | $12K | — | Filing → |